Coming Soon
Find comprehensive information on Intracranial Tumor diagnosis, including clinical documentation, medical coding (ICD-10 codes), healthcare guidelines, and treatment options. Learn about brain tumor symptoms, diagnostic imaging (MRI, CT scan), neurosurgery procedures, and pathology reports related to intracranial neoplasms. This resource provides valuable insights for healthcare professionals, coders, and patients seeking information on intracranial tumors, brain cancer diagnosis, and related medical terminology.
Also known as
Malignant neoplasm of brain
Cancerous tumors originating in the brain.
Benign neoplasm of brain and other parts of central nervous system
Non-cancerous tumors in the brain and central nervous system.
Neoplasm of uncertain or unknown behavior of brain
Brain tumors whose cancerous nature is undetermined.
Malignant neoplasm of meninges
Cancerous tumors affecting the membranes surrounding the brain and spinal cord.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the intracranial tumor malignant?
When to use each related code
| Description |
|---|
| Intracranial Tumor |
| Brain Metastasis |
| Meningioma |
Incorrect coding of tumor histology (e.g., benign vs. malignant) impacts DRG assignment and reimbursement.
Lack of precise documentation of tumor location (lobe, hemisphere) leads to coding errors and claim denials.
Missing or incorrect laterality (right, left, bilateral) affects data accuracy and statistical reporting.
Patient presents with complaints consistent with possible intracranial tumor, including persistent headaches, new-onset seizures, cognitive changes such as memory loss or confusion, nausea, vomiting, vision changes including blurred vision or double vision, balance problems, and personality changes. On neurological examination, findings may include focal neurological deficits, cranial nerve palsies, papilledema, and altered mental status. Differential diagnosis includes brain abscess, stroke, aneurysm, and other neurological conditions. Imaging studies such as MRI brain with and without contrast, CT scan of the head, and PET scan are indicated for diagnosis and characterization of the suspected intracranial neoplasm. Biopsy may be necessary for definitive diagnosis of tumor type and grade, which are essential for treatment planning. Treatment options for intracranial tumors include surgical resection, radiation therapy including stereotactic radiosurgery and whole-brain radiation, chemotherapy, targeted therapy, and supportive care for symptom management. Patient education regarding diagnosis, prognosis, treatment options, and potential complications is crucial. Referral to oncology, neurosurgery, radiation oncology, and palliative care may be warranted depending on the specific tumor type, location, and patient's overall health status. Medical coding for intracranial tumors will utilize ICD-10 codes based on the specific histological diagnosis, and CPT codes will reflect the procedures performed, such as surgical resection, biopsy, radiation therapy, and chemotherapy administration. Ongoing monitoring and follow-up care are essential for assessing treatment response, managing complications, and providing long-term survivorship care.